FTC approves Medtronic acquisition of Covidien

SHARE FTC approves Medtronic acquisition of Covidien

NEW YORK — The U.S. Federal Trade Commission said Wednesday that it approved Medtronic’s $42.9 billion acquisition of Covidien after the medical device maker agreed to sell a business that makes a type of catheter used in veins.

Medtronic said it will sell Covidien’s drug-coated balloon catheter business to Colorado Springs, Colorado-based The Spectranetics Corp. shortly after its acquisition of Covidien closes. Medtronic expects the deal to close early next year. It still needs to be cleared by regulators and authorization from Ireland, where Covidien is based. Both companies’ shareholders also need to approve the acquisition.

Medtronic first announced the deal to buy Covidien in June.

Shares of Minneapolis-based Medtronic shares rose 69 cents to close at $73.48 Wednesday. U.S.-traded shares of Covidien rose $1.22 to close at $100.54. Spectranetics shares rose 29 cents to close at $32.29.

The Latest
Four field houses have been closed and used as shelters for migrants. As the migrant population declines, it’s time to give the facilities back to the neighborhoods.
Former Chicago Police Officer Carlos Yanez said his right eye had to be removed, and there is a lump on his neck, below his right ear, where a bullet remains because doctors believe it too dangerous to remove.
Bears general manager Ryan Poles appears ready to deal the quarterback and use the No. 1 overall pick on USC’s Caleb Williams.
Chicago fell one degree short of the all-time daily record high for February on Tuesday, reaching 74 degrees at O’Hare Airport.
Highlights of Muti’s appearances will include the world premiere of a CSO-commissioned suite from Osvaldo Golijov’s score for Francis Ford Coppola’s soon-to-be-released film, “Megalopolis.”